Michael Forbes, CEO of Adastra, mentioned in his Original press release: “Harm reduction is often a critically important and mainstream matter, and we have been remaining in the forefront of drug polices throughout the board.”May well market substandard and falsified prescription drugs designed or distributed below unregulated and possibly unsa